Challenges and Opportunities of Neoadjuvant Treatment in Locally Advanced Melanoma

Locally advanced and metastatic melanoma have historically had poor survival outcomes. Long-term follow-up of both targeted therapies and immune checkpoint inhibitors has confirmed the survival benefit of these agents in stage IV melanoma, and recent studies have now demonstrated relapse-free surviv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of clinical dermatology 2018-10, Vol.19 (5), p.639-646
Hauptverfasser:	McKean, Meredith A., Amaria, Rodabe N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents, Immunological - pharmacology Antineoplastic Agents, Immunological - therapeutic use Antineoplastic Combined Chemotherapy Protocols - pharmacology Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers Biopsy Cancer therapies Chemoradiotherapy, Adjuvant - methods Clinical trials Clinical Trials as Topic Costimulatory and Inhibitory T-Cell Receptors - antagonists & inhibitors Costimulatory and Inhibitory T-Cell Receptors - immunology Dermatologic Surgical Procedures - methods Dermatology Drug Resistance, Neoplasm Humans Immunotherapy Leading Article Lymphatic system Medical prognosis Medical research Medicine Medicine & Public Health Melanoma Melanoma - immunology Melanoma - mortality Melanoma - pathology Melanoma - therapy Metastasis Molecular Targeted Therapy - methods Mutation Neoadjuvant Therapy - adverse effects Neoadjuvant Therapy - methods Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - prevention & control Pharmacology/Toxicology Pharmacotherapy Skin - pathology Skin cancer Skin Neoplasms - immunology Skin Neoplasms - mortality Skin Neoplasms - pathology Skin Neoplasms - therapy Toxicity Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!